?> Contact us Follow Us
Biosimilars Forum
  • About Us
    • Members
    • Executive Director
  • Why Biosimilars
    • The Issue
    • Our Solutions
  • Biosimilars 101
    • Foundations
    • Core Principles
    • FDA Regulatory Tenets
    • Biosimilars FAQs
  • Advocacy
    • Our Action
    • Tools
  • News
  • Resources
  • Get Involved
    • Partners

Carlos Angeles

Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
September 9, 2019 Carlos Angeles
Biosimilars Forum’s Public Letter In Response to Anti-Biosimilars Op-Ed
News
August 22, 2019 Carlos Angeles
New Analysis Encourages Employer Engagement to Help Realize Significant Savings Potential of Biosimilars
News
July 30, 2019 Carlos Angeles
Forum Statement in Response to Senate Finance Committee Advancing its Drug Pricing Package
News
July 25, 2019 Carlos Angeles
Forum Statement on Senate Finance Provision and New Amendment That Could Save Taxpayers and Seniors Billions
News
July 23, 2019 Carlos Angeles
Senate Finance Provision Increasing ASP for Biosimilars Could Unlock Billions in Savings for Patients and Taxpayers
News
July 11, 2019 Carlos Angeles
New Analysis Confirms Increased Use of Biosimilars Can Save U.S. Up to $71 Billion Over a Decade
News
June 20, 2019 Carlos Angeles
Health Experts Agree Increasing Biosimilar Use Can Help Reduce Rising Drug Costs for Patients
News
May 29, 2019 Carlos Angeles
Biosimilars Forum Announces Support for Policies that Would Save Taxpayers and Seniors Billions
News
May 23, 2019 Carlos Angeles
The Biosimilars Forum Commends Senate HELP Committee’s Effort to Educate Patients and Providers on Biosimilars
News
March 19, 2019 Carlos Angeles
Significant Healthcare Savings Possible if U.S. Cultivates a Robust Biosimilars Market
  • 01
  • 02
  • 03
  • Next page

  • Biosimilars 101
  • Biosimilars FAQs
  • Advocacy
  • Stay Connected
Biosimilars Forum
© 2022 Biosimilars Forum. All rights reserved.
  • Terms of Use
  • |
  • Privacy Policy
  • |
  • Contact Us